Research ArticleOriginal Research

Patterns of Clinical Care Subsequent to Nonindicated Vitamin D Testing in Primary Care

Michelle S. Rockwell, YingXing Wu, Mariana Salamoun, Matthew W. Hulver and John W. Epling
The Journal of the American Board of Family Medicine July 2020, 33 (4) 569-579; DOI: https://doi.org/10.3122/jabfm.2020.04.200007

References

  1. 1.↵
    1. Shrank WH,
    2. Rogstad TL,
    3. Parekh N
    . Waste in the US health care system: estimated costs and potential for savings. JAMA 2019;322:1501–9.
    OpenUrl
  2. 2.↵
    1. Colla CH,
    2. Mainor AJ,
    3. Hargreaves C,
    4. Sequist T,
    5. Morden N
    . Interventions aimed at reducing use of low-value health services: a systematic review. Med Care Res Rev 2017;74:507–50.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Miller G,
    2. Rhyan C,
    3. Beaudin-Seiler B,
    4. Hughes-Cromwick P
    . A framework for measuring low-value care. Value Health 2018;21:375–9.
    OpenUrl
  4. 4.↵
    Choosing Wisely. Available from: http://www.choosingwisely.org/. Accessed November 2019.
  5. 5.↵
    1. Reschovsky JD,
    2. Rich EC,
    3. Lake TK
    . Factors contributing to variations in physicians' use of evidence at the point of care: a conceptual model. J Gen Intern Med 2015;30:555–61.
    OpenUrl
  6. 6.↵
    American Society for Clinical Pathology Choosing Wisely recommendations. Available from: http://www.choosingwisely.org/clinician-lists/american-society-Clinical-Pathology-population-based-screening-for-vitamin-d-deficiency/. Published February 21, 2013. Accessed October 2019.
  7. 7.↵
    1. LeFevre ML
    . Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2015;162:133–40.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Holick MF,
    2. Binkley NC,
    3. Bischoff-Ferrari HA,
    4. et al
    . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Ross AC,
    2. Manson JE,
    3. Abrams SA,
    4. et al
    . The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53–8.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Rockwell M,
    2. Kraak V,
    3. Hulver M,
    4. Epling J
    . Clinical management of low vitamin D: a scoping review of physicians' practices. Nutrients 2018;10:493.
    OpenUrl
  11. 11.↵
    Virginia low value services report (2016). Available from: https://www.vhi.org/apcd/Virginia%20Low%20Value%20Services%20Report.pdf.
  12. 12.↵
    1. Bilinski KL,
    2. Boyages SC
    . The rising cost of vitamin D testing in Australia: time to establish guidelines for testing. Med J Aust 2012;197:90.
    OpenUrlPubMed
  13. 13.↵
    1. Colla CH,
    2. Morden NE,
    3. Sequist TD,
    4. Mainor AJ,
    5. Li Z,
    6. Rosenthal MB
    . Payer type and low-value care: comparing Choosing Wisely services across commercial and Medicare populations. Health Serv Res 2018;53:730–746.
    OpenUrl
  14. 14.↵
    1. Bilinski K,
    2. Boyages S
    . Evidence of overtesting for vitamin D in Australia: an analysis of 4.5 years of Medicare Benefits Schedule (MBS) data. BMJ Open 2013;3:e002955.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Bilinski K,
    2. Boyages S
    . The rise and rise of vitamin D testing. BMJ 2012;345:e4743.
    OpenUrlFREE Full Text
  16. 16.↵
    1. Caillet P,
    2. Goyer-Joos A,
    3. Viprey M,
    4. et al
    . Increase of vitamin D assays prescriptions and associated factors: a population-based cohort study. Sci Rep 2017;7:10361.
    OpenUrl
  17. 17.↵
    1. Shahangian S,
    2. Alspach TD,
    3. Astles JR,
    4. Yesupriya A,
    5. Dettwyler WK
    . Trends in laboratory test volumes for Medicare Part B reimbursements, 2000–2010. Arch Pathol Lab Med 2014;138:189–203.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Khalifa M,
    2. Zabani I,
    3. Khalid P
    . Exploring lab tests over utilization patterns using health analytics methods. Stud Health Technol Inform 2016;226:190–193.
    OpenUrl
  19. 19.↵
    1. Colla CH,
    2. Morden NE,
    3. Sequist TD,
    4. Schpero WL,
    5. Rosenthal MB
    . Choosing Wisely: prevalence and correlates of low-value health care services in the United States. J Gen Intern Med 2015;30:221–228.
    OpenUrlCrossRefPubMed
  20. 20.↵
    Excellus: low value vitamin D testing in upstate NY. Available from: https://www.bcbs.com/news/press-releases/most-people-dont-need-vitamin-d-testing. Accessed November 2019.
  21. 21.↵
    1. Rodd C,
    2. Sokoro A,
    3. Lix LM,
    4. et al
    . Increased rates of 25-hydroxy vitamin D testing: dissecting a modern epidemic. Clin Biochem 2018;59:56–61.
    OpenUrl
  22. 22.↵
    1. Woodford HJ,
    2. Barrett S,
    3. Pattman S
    . Vitamin D: too much testing and treating?. Clin Med 2018;18:196–200.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Mafi JN,
    2. Russell K,
    3. Bortz BA,
    4. Dachary M,
    5. Hazel WA Jr..,
    6. Fendrick AM
    . Low-cost, high-volume health services contribute the most to unnecessary health spending. Health Aff (Millwood) 2017;36:1701–1704.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Rozario NL,
    2. Sparling A,
    3. Burns R,
    4. et al
    . Modifying provider vitamin D screening behavior in primary care. J Am Board Fam Med 2020;33:252–261.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Carter EA,
    2. Morin PE,
    3. Lind KD
    . Costs and trends in utilization of low-value services among older adults with commercial insurance or Medicare advantage. Med Care 2017;55:931–939.
    OpenUrl
  26. 26.↵
    1. Krasowski MD,
    2. Chudzik D,
    3. Dolezal A,
    4. et al
    . Promoting improved utilization of laboratory testing through changes in an electronic medical record: experience at an academic medical center. BMC Med Inform Decis Mak 2015;15:11.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Naugler C,
    2. Ma I
    . More than half of abnormal results from laboratory tests ordered by family physicians could be false-positive. Can Fam Physician 2018;64:202–203.
    OpenUrlFREE Full Text
  28. 28.↵
    1. Webster BS,
    2. Choi Y,
    3. Bauer AZ,
    4. Cifuentes M,
    5. Pransky G
    . The cascade of medical services and associated longitudinal costs due to nonadherent magnetic resonance imaging for low back pain. Spine 2014;39:1433–1440.
    OpenUrl
  29. 29.↵
    1. von Elm E,
    2. Altman DG,
    3. Egger M,
    4. Pocock SJ,
    5. Gøtzsche PC,
    6. Vandenbroucke JP
    ; for the STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007;147:573–577.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Morgen EK,
    2. Naugler C
    . Inappropriate repeats of six common tests in a canadian city: a population cohort study within a laboratory informatics framework. Am J Clin Pathol 2015;144:704–712.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Pepper KJ,
    2. Judd SE,
    3. Nanes MS,
    4. Tangpricha V
    . Evaluation of vitamin D repletion regimens to correct vitamin D status in adults. Endocr Pract 2009;15:95–103.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Caillet P,
    2. Souberbielle JC,
    3. Jaglal SB,
    4. et al
    . Vitamin D supplementation in a healthy, middle-aged population: actual practices based on data from a French comprehensive regional health-care database. Eur J Clin Nutr 2013;67:1133–1137.
    OpenUrl
  33. 33.↵
    1. Tarn DM,
    2. Paterniti DA,
    3. Wenger NS
    . Clinician recommendations in the face of scientific uncertainty: an analysis of audio-recorded discussions about vitamin D. J Gen Intern Med 2016;31:909–917.
    OpenUrl
  34. 34.↵
    1. Epling JW,
    2. Mader EM,
    3. Roseamelia CA,
    4. Morley CP
    . Emerging practice concerning vitamin D in primary care. Qual Health Res 2015;25:1005–1012.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Hofstede H,
    2. van der Burg HAM,
    3. Mulder BC,
    4. et al
    . Reducing unnecessary vitamin testing in general practice: barriers and facilitators according to general practitioners and patients. BMJ Open 2019;9:e029760.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Genzen JR,
    2. Gosselin JT,
    3. Wilson TC,
    4. Racila E,
    5. Krasowski MD
    . Analysis of vitamin D status at two academic medical centers and a national reference laboratory: result patterns vary by age, gender, season, and patient location. BMC Endocr Disord 2013;13:52–52.
    OpenUrl
  37. 37.↵
    1. Bailey BA,
    2. Manning T,
    3. Peiris AN
    . Vitamin D testing patterns among six Veterans Medical Centers in the Southeastern United States: links with medical costs. Mil Med 2012;177:70–76.
    OpenUrlPubMed
  38. 38.↵
    1. Stratton-Loeffler MJ,
    2. Lo JC,
    3. Hui RL,
    4. Coates A,
    5. Minkoff JR,
    6. Budayr A
    . Treatment of vitamin D deficiency within a large integrated health care delivery system. J Manag Care Pharm 2012;18:497–505. Available from: https://pubmed.ncbi.nlm.nih.gov/22971203/.
    OpenUrlPubMed
  39. 39.↵
    1. Petrilli CM,
    2. Henderson J,
    3. Keedy JM,
    4. et al
    . Reducing unnecessary vitamin D screening in an academic health system: what works and when. Am J Med 2018;131:1444–1448.
    OpenUrl
  40. 40.↵
    1. Isaac T,
    2. Rosenthal MB,
    3. Colla CH,
    4. et al
    . Measuring overuse with electronic health records data. Am J Manag Care 2018;24:19–25. Available from: https://pubmed.ncbi.nlm.nih.gov/29350509/.
    OpenUrlPubMed
  41. 41.↵
    CDC. Dietary supplement usage among U.S. adults. Available from: https://www.cdc.gov/nchs/data/databriefs/db61.htm. Accessed November 2019.
  42. 42.↵
    1. Płudowski P,
    2. Karczmarewicz E,
    3. Bayer M,
    4. et al
    . Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe—recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol 2013;64:319–327.
    OpenUrlCrossRefPubMed
  43. 43.↵
    American Academy of Family Physicians. Clinical preventive service recommendation—vitamin D deficiency. Available from: https://wwwaafporg/patient-care/Clinical-recommendations/all/vitamin-D-deficiencyhtml. Accessed January 2020.
  44. 44.↵
    1. Shieh A,
    2. Chun RF,
    3. Ma C,
    4. et al
    . Effects of high-dose vitamin D2 versus D3 on total and free 25-hydroxyvitamin D and markers of calcium balance. J Clin Endocrinol Metab 2016;101:3070–3078.
    OpenUrl
  45. 45.↵
    1. Tripkovic L,
    2. Lambert H,
    3. Hart K,
    4. et al
    . Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 2012;95:1357–1364.
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    1. Houben PH,
    2. van der Weijden T,
    3. Winkens B,
    4. Winkens RA,
    5. Grol RP
    . Pretest expectations strongly influence interpretation of abnormal laboratory results and further management. BMC Fam Pract 2010;11:13.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Ganguli I,
    2. Lupo C,
    3. Mainor AJ,
    4. et al
    . Prevalence and cost of care cascades after low-value preoperative electrocardiogram for cataract surgery in fee-for-service Medicare beneficiaries. JAMA Intern Med 2019;179:1211–1219.
    OpenUrl
  48. 48.↵
    1. Bhatia RS,
    2. Bouck Z,
    3. Iyers NM,
    4. et al
    . Electrocardiograms in low-risk patients undergoing an annual health examination. JAMA Intern Med 2017;177:1326–1335.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords